Zephir H - Search Results

1

Evaluation of efficacy and tolerability of first-line therapies in NMOSD.

Poupart J, Giovannelli J, Deschamps R, Audoin B, Ciron J, Maillart E, Papeix C, Collongues N, Bourre B, Cohen M, Wiertlewski S, Outteryck O, Laplaud D, Vukusic S, Marignier R, Zephir H; NOMADMUS study group. Poupart J, et al. Among authors: zephir h. Neurology. 2020 Apr 14;94(15):e1645-e1656. doi: 10.1212/WNL.0000000000009245. Epub 2020 Mar 13. Neurology. 2020. PMID: 32170036

2

[Treatment of progressive multiple sclerosis with cyclophosphamide].

Zephir H, De Seze J, Sénéchal O, Stojkovic T, Ferriby D, Deliss B, Dubus B, Verier A, Hautecoeur P, Vermersch P. Zephir H, et al. Rev Neurol (Paris). 2002 Jan;158(1):65-9. Rev Neurol (Paris). 2002. PMID: 11938324 French.

3

[Epstein-Barr meningoencephaloradiculitis in a immunocompetent woman].

Zephir H, De Seze J, Ferriby D, Stojkovic T, Vermersch P. Zephir H, et al. Rev Neurol (Paris). 2002 Sep;158(8-9):830-2. Rev Neurol (Paris). 2002. PMID: 12386530 French.

4

Multiple sclerosis and depression: influence of interferon beta therapy.

Zephir H, De Seze J, Stojkovic T, Delisse B, Ferriby D, Cabaret M, Vermersch P. Zephir H, et al. Mult Scler. 2003 Jun;9(3):284-8. doi: 10.1191/1352458503ms915oa. Mult Scler. 2003. PMID: 12814176

5

Treatment of progressive forms of multiple sclerosis by cyclophosphamide: a cohort study of 490 patients.

Zephir H, de Seze J, Duhamel A, Debouverie M, Hautecoeur P, Lebrun C, Malikova I, Pelletier J, Sénéchal O, Vermersch P. Zephir H, et al. J Neurol Sci. 2004 Mar 15;218(1-2):73-7. doi: 10.1016/j.jns.2003.11.004. J Neurol Sci. 2004. PMID: 14759636 Clinical Trial.

6

New insights into cell responses involved in experimental autoimmune encephalomyelitis and multiple sclerosis.

El Behi M, Dubucquoi S, Lefranc D, Zéphir H, De Seze J, Vermersch P, Prin L. El Behi M, et al. Among authors: zephir h. Immunol Lett. 2005 Jan 15;96(1):11-26. doi: 10.1016/j.imlet.2004.07.017. Immunol Lett. 2005. PMID: 15585303 Review.

7

One-year cyclophosphamide treatment combined with methylprednisolone improves cognitive dysfunction in progressive forms of multiple sclerosis.

Zéphir H, de Seze J, Dujardin K, Dubois G, Cabaret M, Bouillaguet S, Ferriby D, Stojkovic T, Vermersch P. Zéphir H, et al. Mult Scler. 2005 Jun;11(3):360-3. doi: 10.1191/1352458505ms1172sr. Mult Scler. 2005. PMID: 15957521 Clinical Trial.

8

Unusual ocular motor findings in multiple sclerosis.

de Seze J, Vukusic S, Viallet-Marcel M, Tilikete C, Zéphir H, Delalande S, Stojkovic T, Defoort-Dhellemmes S, Confavreux C, Vermersch P. de Seze J, et al. Among authors: zephir h. J Neurol Sci. 2006 Apr 15;243(1-2):91-5. doi: 10.1016/j.jns.2005.11.022. Epub 2006 Feb 8. J Neurol Sci. 2006. PMID: 16466746

9

Pathologic laughing and intractable hiccups can occur early in multiple sclerosis.

de Seze J, Zephir H, Hautecoeur P, Mackowiak A, Cabaret M, Vermersch P. de Seze J, et al. Among authors: zephir h. Neurology. 2006 Nov 14;67(9):1684-6. doi: 10.1212/01.wnl.0000242625.75753.69. Neurology. 2006. PMID: 17101907

10

Acute fulminant demyelinating disease: a descriptive study of 60 patients.

de Seze J, Debouverie M, Zephir H, Lebrun C, Blanc F, Bourg V, Wiertlewski S, Pittion S, Laplaud D, Le Page E, Deschamps R, Cabre P, Pelletier J, Malikova I, Clavelou P, Jaillon V, Defer G, Labauge P, Gout O, Boulay C, Edan G, Vermersch P. de Seze J, et al. Among authors: zephir h. Arch Neurol. 2007 Oct;64(10):1426-32. doi: 10.1001/archneur.64.10.1426. Arch Neurol. 2007. PMID: 17923626

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

200 results

Search Page

Filters